IHS Chemical Week

Regions :: China

Amerigen Pharmaceuticals, Ningbo Menovo sign generics deal; Menovo to manufacture APIs

3:02 AM MDT | August 28, 2014 | Deepti Ramesh

Amerigen Pharmaceuticals (Lyndhurst, NJ) and Ningbo Menovo Pharmaceutical (Ningbo, China) have entered into a collaboration agreement for the development of generic pharmaceuticals, primarily targeting the US market. Amerigen and Menovo, under the terms of the agreement, will jointly develop products for Amerigen to commercialize in the United States. Menovo will be responsible for manufacturing the active pharmaceutical ingredient (API) and finished product whereas Amerigen will be responsible for clinical, regulatory and commercial activities in the United...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa